Delivery Order SPE2DB22D3004-SPE2DB25FSA38
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Protonix 40 mg suspension (30-count units) on June 18, 2025, with a ceiling value of $1,461.88 and completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pharmaceutical supply to support federal medical procurement needs. The award was issued without set-aside designation, reflecting AmerisourceBergen's established capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $4,464.45 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Protonix 40 mg suspension in 30-unit quantities. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-competitive, non-set-aside award. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,345.81 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30-count). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of January 5, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30-count) under a firm fixed-price contract. The award, issued on October 28, 2025, carries a ceiling value of $1,156.78 and is scheduled for completion by October 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.81 for Pantoprazole Sodium delayed-release 40 mg tablets (90-count) on January 2, 2026, with completion scheduled for January 5, 2026. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- This federal contract award is for the delivery of Protonix 40 mg suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,151.59, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 26, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $7,351.73. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded competitively. The contract is scheduled for ultimate completion on November 6, 2025, and performance will take place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $895 to Amerisourcebergen Drug Corporation for 1,000 tablets of 40mg pantoprazole sodium delayed release. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The single day order is to be completed on August 10, 2023 under an existing indefinite delivery/indefinite quantity contract vehicle. As the largest medical supply agency within the...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium Delayed-Release 20 mg tablets (90-count) with a ceiling value of $10,425.69. This competitively awarded, non-set-aside contract with firm fixed pricing is effective through September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSA38Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,773.18 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion vehicle extending through December 2026 that enables the distributor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program Generation V is expected to make multiple regional awards, positioning AmerisourceBergen among key strategic partners for military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/15/25 |